Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors
Status:
Completed
Trial end date:
2016-10-10
Target enrollment:
Participant gender:
Summary
RATIONALE: Panobinostat may stop the growth of tumor cells by blocking some of the enzymes
needed for cell growth. Drugs used in chemotherapy, such as epirubicin, work in different
ways to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Giving panobinostat together with epirubicin may kill more tumor cells.
PURPOSE: This phase I trial is studying the side effects and best dose of panobinostat when
given together with epirubicin in treating patients with metastatic malignant solid tumors.